On Registration of the Prospectus for Nominal Coupon Bonds of “Solis” Closed Joint-Stock Company
THE CENTRAL BANK OF THE REPUBLIC OF ARMENIA
GOVERNOR DECISION
May 20, 2026 No. 1/219 A
On Registration of the Prospectus for Nominal Coupon Bonds of “Solis” Closed Joint-Stock Company
Whereas, on April 27, 2026, “Solis” Closed Joint-Stock Company submitted to the Central Bank of the Republic of Armenia an application for the registration of a prospectus for nominal coupon bonds with a face value of USD 100 (one hundred United States dollars), in a total amount of USD 2,000,000 (two million United States dollars), comprising 20,000 (twenty thousand) bonds, bearing an annual yield of 8% (eight percent) and a maturity period of 48 (forty-eight) months, together with the prospectus and all documents and supporting materials required for prospectus registration pursuant to the Republic of Armenia Law “On the Securities Market”, and Regulation 4/04 “Prospectus and Statements of Reporting Issuers” as approved by Board Resolution No. 68-N, dated March 11, 2008, of the Central Bank of the Republic of Armenia;
Based on the foregoing, and
Pursuant to Article 2(3) of the Republic of Armenia Law “On the Central Bank of the Republic of Armenia”, and Article 10 of the Republic of Armenia Law “On the Securities Market”, and the conclusion issued by the Licensing and Supervision Committee of the Central Bank of the Republic of Armenia (Minutes No. 25, dated May 20, 2026),
Decided:
1. Register the prospectus for nominal coupon bonds with a face value of USD 100 (one hundred United States dollars), in a total amount of USD 2,000,000 (two million United States dollars), comprising 20,000 (twenty thousand) bonds, bearing an annual yield of 8% (eight percent) and a maturity period of 48 (forty-eight) months, which “Solis” Closed Joint-Stock Company submitted to the Central Bank of the Republic of Armenia on April 27, 2026.
2. This decision to take effect upon acknowledgment of its receipt by “Solis” CJSC or “Ameriabank” CJSC, or on the day following its duly prescribed delivery to an authorized representative of “Solis” CJSC.
Martin Galstyan
.